rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2002-3-7
|
pubmed:abstractText |
A study of the S1 binding of lead 5-methylthiothiophene amidine 3, an inhibitor of urokinase-type plasminogen activator, was undertaken by the introduction of a variety of substituents at the thiophene 5-position. The 5-alkyl substituted and unsubstituted thiophenes were prepared using organolithium chemistry. Heteroatom substituents were introduced at the 5-position using a novel displacement reaction of 5-methylsulfonylthiophenes and the corresponding oxygen or sulfur anions. Small alkyl group substitution at the 5-position provided inhibitors equipotent with but possessing improved solubility.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0960-894X
|
pubmed:author |
pubmed-author:BoneRogerR,
pubmed-author:DeckmanIngrid CIC,
pubmed-author:DesJarlaisRenée LRL,
pubmed-author:GrasbergerBruce LBL,
pubmed-author:GreenDavidD,
pubmed-author:HoffmanJames BJB,
pubmed-author:IlligCarl RCR,
pubmed-author:LewandowskiFrankF,
pubmed-author:MaguireDianeD,
pubmed-author:MantheyCarlC,
pubmed-author:MolloyChris JCJ,
pubmed-author:NgoR LRL,
pubmed-author:RandleTroyT,
pubmed-author:RudolphM JonathanMJ,
pubmed-author:SharpCeliaC,
pubmed-author:SollRichard MRM,
pubmed-author:SpurlinoJohn CJC,
pubmed-author:SubasingheNalin LNL,
pubmed-author:WilsonKenneth JKJ,
pubmed-author:ZhangMarieM
|
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
491-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
|
pubmed:year |
2002
|
pubmed:articleTitle |
Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitors.
|
pubmed:affiliation |
3-Dimensional Pharmaceuticals Inc., 665 Stockton Drive, Exton, PA 19341, USA. rudolph@3dp.com
|
pubmed:publicationType |
Journal Article
|